LataMed AI Corp.
LMEDdata completeness 75%3 fiscal years on fileData notes: no data for concept 'capex'; no data for concept 'totalDebt'; no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'depreciationAmortization'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'; no data for concept 'dividendsPaid'
| Figure | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Revenue | $01 | $02 | $02 |
| Net income | −$1.73M3 | −$3.26M4 | −$207,4854 |
| Operating cash flow | −$70,3015 | −$66,8346 | −$205,7916 |
| Capital expenditure | — | — | — |
| Free cash flow (derived) | — | — | — |
| Total debt | — | — | — |
| Cash & equivalents | $07 | $07 | $07 |
| Diluted shares | 88.9M | 29.3M | 44.3M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on −$0.14 of net worth that earned you −$0.05 last year.
Not enough data in the filings for a return-on-capital reading.
seeing a moat in the numbers →Share count is down 50% over 3 years — management has been buying back stock, quietly handing owners a bigger slice.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2023-12-31 · accession 0001477932-25-002922 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K/A · period ending 2024-12-31 · accession 0001477932-26-002727 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001477932-25-002922 (NetIncomeLoss)
- 10-K/A · period ending 2024-12-31 · accession 0001477932-26-002727 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001477932-25-002922 (NetCashProvidedByUsedInOperatingActivities)
- 10-K/A · period ending 2024-12-31 · accession 0001477932-26-002727 (NetCashProvidedByUsedInOperatingActivities)
- 10-K/A · period ending 2023-12-31 · accession 0001477932-26-002727 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)